Almost everyone these days knows someone who has had a hip replacement; this type of surgery has become very common.
The problem is, many of the hip implants that were manufactured for this surgery, were defective and caused unwitting patients to suffer serious complications. Certain implants were recalled due to patient safety issues, and class action litigation on behalf of injured patients was commenced a couple of years ago against the manufacturer of these defective hip implants, known commonly as “Stryker implants.” The corporate name of the manufacturer is Howmedica Osteonics Corp. (“Stryker.”)
Last November 3, 2014, Stryker announced the formation of a National Settlement Program for affected patients who had received selected Stryker implants, and who met certain criteria. Stryker invited patients who had received the “Rejuvenate” and “ABG II” hip systems to participate in the settlement program, but also required that substantially all other eligible patients participate. Stryker offered the settlement program only to patients who have had their Stryker implant removed prior to November 3, 2014; who registered with the program online by December 16, 2014; and who enroll in the program by a deadline was extended to March 30, 2015.